HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C
- PMID: 19935663
- PMCID: PMC2887091
- DOI: 10.1038/ng.486
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C
Abstract
A variant 35 kb upstream of the HLA-C gene (-35C/T) was previously shown to associate with HLA-C mRNA expression level and steady-state plasma HIV RNA levels. We genotyped this variant in 1,698 patients of European ancestry with HIV. Individuals with known seroconversion dates were used for disease progression analysis and those with longitudinal viral load data were used for viral load analysis. We further tested cell surface expression of HLA-C in normal donors using an HLA-C-specific antibody. We show that the -35C allele is a proxy for high HLA-C cell surface expression, and that individuals with high-expressing HLA-C alleles progress more slowly to AIDS and control viremia significantly better than individuals with low HLA-C expressing alleles. These data strongly implicate high HLA-C expression levels in more effective control of HIV-1, potentially through better antigen presentation to cytotoxic T lymphocytes or recognition and killing of infected cells by natural killer cells.
Figures
References
-
- Carrington M, O’Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med. 2003;54:535–551. - PubMed
-
- Gao X, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med. 2001;344:1668–1675. - PubMed
-
- Gao X, et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med. 2005;11:1290–1292. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R56 DA004334/DA/NIDA NIH HHS/United States
- R01-DA04334/DA/NIDA NIH HHS/United States
- R01 DA004334/DA/NIDA NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- R01-DA12568/DA/NIDA NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- N02 CP055504/CP/NCI NIH HHS/United States
- R01 DA012568/DA/NIDA NIH HHS/United States
- HHSN261200800001C/RC/CCR NIH HHS/United States
- P30 AI27763/AI/NIAID NIH HHS/United States
- HHSN261200800001E/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
